Startups
Drugs developer for the treatment of neurodegenerative and neuroinflammatory diseases.
Summary
21
Total funding Amount
$21M
Fundraising History
-
Mar 22 '10 Series D$350K
-
Oct 24 '06 Series C$13M
-
Oct 19 '05 Series B$4.3M
Investors
-
Aescap Venture
Series C -
EMBL Ventures
Series B